Results per Page:
Cell death on a chip: new tools for a new era of cancer biology
From The Folch Lab, University of Washington Bioengineering Department and Cancer Basic Biology Program of the Cancer Consortium
Making the most of a small supply
Fred Hutch researchers receive $1.3 million grant from the U.S. Department of Defense to study the fundamental biology of five rare liver cancers that could lead to new treatments one day
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Charting new territory in detangling cytokine secretion mechanisms
From the Gujral Lab, Human Biology Division
Fred Hutch launches rare cancer research effort
New TRACER initiative aims to accelerate advances through multidisciplinary collaboration and innovative approaches
Six researchers receive $3.5 million in grants from Kuni Foundation
Funds will support innovative high-risk/high-reward projects across Fred Hutchinson Cancer Center/University of Washington/Seattle Children’s Cancer Consortium with the potential to revolutionize care
Fred Hutch/UW/Seattle Children’s Cancer Consortium breast cancer researchers receive grants
Breast Cancer Research Foundation supports projects including new imaging tracer, better risk prediction for luminal B subtypes, anti-inflammatory vaccine and more
Machine learning identifies biomarkers that predict a patient’s response to immunotherapy
From the Gujral Lab, Human Biology Division
Drug identified to combat Omicron-induced cytokine storm
From the Gujral Lab, Human Biology Division
Development of an in vitro model system to study tricky-to-target tumor microenvironment cells
From the Gujral Lab, Human Biology Division
Computational predictions reveal an unexpected synergy for prostate cancer therapy
From the Gujral Lab, Human Biology Division
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
New strategy to weather the (cytokine) storm
From the Gujral Lab, Human Biology Division
Liver cancer researcher Dr. Abir Arfaoui named latest Brave Fellow
Running community honors late athlete Gabe Grunewald by funding rare cancer research at Fred Hutch
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Tip Sheet: New COVID-19 transmission study, returning to school, video of biorepositories — and a new weight loss study
Summaries of recent Fred Hutch research findings and other news
Outlining the molecular networks that alter cell function and behavior
Dr. Taran Gujral’s NSF CAREER Award will allow him to study how cells shift to new functional states in normal development and disease
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
New awards to spur innovation, commercialization in life sciences research
Funding from Washington Research Foundation continues longstanding collaboration with Fred Hutch